NO20034098L - Östrogenerstatningsterapi - Google Patents

Östrogenerstatningsterapi

Info

Publication number: NO20034098L
Authority: NO; Norway
Prior art keywords: östrogenerstatningsterapi
Prior art date: 2001-03-16

Application number

NO20034098A

Other languages

English (en)

Other versions

NO20034098D0 (no

Inventor

James Harrison Pickar

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-16

Filing date

2003-09-15

Publication date

2003-11-13

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23057754&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20034098(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-09-15 Application filed by Wyeth Corp filed Critical Wyeth Corp

2003-09-15 Publication of NO20034098D0 publication Critical patent/NO20034098D0/no

2003-11-13 Publication of NO20034098L publication Critical patent/NO20034098L/no

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Neurology (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Epidemiology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Dermatology (AREA)
Vascular Medicine (AREA)
Oncology (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Communicable Diseases (AREA)
Pain & Pain Management (AREA)
Virology (AREA)
Gastroenterology & Hepatology (AREA)
Hematology (AREA)
Obesity (AREA)
Transplantation (AREA)

NO20034098A 2001-03-16 2003-09-15 Östrogenerstatningsterapi NO20034098L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US27670401P	2001-03-16	2001-03-16
PCT/US2002/007971 WO2002078682A2 (en)	2001-03-16	2002-03-15	Estrogen replacement therapy

Publications (2)

Publication Number	Publication Date
NO20034098D0 NO20034098D0 (no)	2003-09-15
NO20034098L true NO20034098L (no)	2003-11-13

Family

ID=23057754

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20034098A NO20034098L (no)	2001-03-16	2003-09-15	Östrogenerstatningsterapi

Country Status (18)

Country	Link
US (2)	US20020173499A1 (no)
EP (1)	EP1368037A2 (no)
JP (1)	JP2004524354A (no)
KR (1)	KR20030090673A (no)
CN (2)	CN1633299A (no)
AR (1)	AR035946A1 (no)
AU (1)	AU2002338277B2 (no)
BR (1)	BR0208165A (no)
CA (1)	CA2441252A1 (no)
EA (1)	EA200301023A1 (no)
HU (1)	HUP0500346A2 (no)
IL (1)	IL157943A0 (no)
MX (1)	MXPA03008366A (no)
NO (1)	NO20034098L (no)
PL (1)	PL364675A1 (no)
SG (1)	SG154323A1 (no)
WO (1)	WO2002078682A2 (no)
ZA (1)	ZA200308029B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1555266A (zh) *	2001-03-16	2004-12-15		激素替代疗法
EP1857110A3 (en) *	2001-03-16	2008-08-06	Wyeth	Hormone replacement therapy
JP5143993B2 (ja) *	2003-03-26	2013-02-13	株式会社産学連携機構九州	エストロゲン様活性剤
WO2004091535A2 (en) *	2003-04-11	2004-10-28	Barr Laboratories, Inc.	Methods of administering estrogens and progestins
US20060040904A1 (en) *	2004-08-17	2006-02-23	Ahmed Salah U	Vaginal cream compositions, kits thereof and methods of using thereof
BRPI0514628A (pt) *	2004-08-26	2008-06-17	Wyeth Corp	composto ou um sal farmaceuticamente aceitável do mesmo, método para tratar ou inibir doenças, métodos para baixar os nìveis de colesterol, triglicerìdeos, lp(a), ou ldl; ou inibir avaria da parede vascular, para prover aumento de cognição ou neuroproteção; para tratar ou inibir estados doentios induzidos por radical livre, condições, e inchação ou erosão de junta; ou tratar ou inibir avaria de junta secundária a procedimentos artroscópicos ou cirúrgicos, e, composição farmacêutica
US8217024B2 (en) *	2005-12-27	2012-07-10	Teva Women's Health, Inc.	Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
US20070264309A1 (en) *	2006-01-20	2007-11-15	Chollet Janet A	Method Of Treating Atrophic Vaginitis
CA2644913A1 (en) *	2006-04-05	2007-10-18	Wyeth	Methods for prevention and treatment of conditions arising from local estrogen deficiency
US20070254036A1 (en)	2006-04-13	2007-11-01	Besins Healthcare Sa	Treatment of menopause associated symptoms
KR20090029237A (ko)	2006-06-02	2009-03-20	피어 트리 파머슈티칼스 인코포레이티드	위축성 질염을 치료하는 방법
EP2044943A1 (en) *	2007-10-04	2009-04-08	Solvay Pharmaceuticals, Inc.	Pharmaceutical compositions comprising esterified estrogens and methyltestosterone and method of using the same
AU2008325211B2 (en) *	2007-11-06	2014-11-13	Signal Coordinating Therapy, Inc.	Compositions and methods for treating Parkinson's disease and related disorders
WO2010033188A2 (en) *	2008-09-16	2010-03-25	Playtex Products, Llc.	Dosages for menstrual suppression, contraception, and hormone replacement therapy, and methods of administering same
KR101665261B1 (ko)	2015-08-06	2016-10-12	순천향대학교 산학협력단	위축성 질염의 치료용 조성물 및 위축성 질염의 진단용 마커 조성물
CN114573654B (zh) *	2020-12-01	2025-09-12	北京奇明达企业管理有限公司	17-O-乙酰-17-β雌二醇的自组装的三聚体、其制备、活性和应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1175468A (en) *	1967-10-19	1969-12-23	Merck Ag E	Pharmaceutical Compositions
US3608075A (en) *	1969-07-28	1971-09-21	American Home Prod	Compositions and methods of treating the menopausal syndrome
US4154820A (en) *	1976-02-23	1979-05-15	Akzona Incorporated	Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
US4826831A (en) *	1983-08-05	1989-05-02	Pre Jay Holdings Limited	Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
EP0322020A1 (en) *	1987-12-22	1989-06-28	Akzo N.V.	Pharmaceutical dosage unit for treating climacteric complaints and osteoporosis
US4980358A (en) *	1988-04-04	1990-12-25	George D. McAdory	Method employing gonadal hormones and dopamine agonist intended for combined use in the improvement of lymphocyte function
IT1244697B (it) *	1991-02-01	1994-08-08	Chiesi Farma Spa	Associazione farmaceutica per la prevenzione e il trattamento dell'osteoporosi post-menopausale
IL107343A (en) *	1992-11-02	2003-10-31	Wyeth Corp	PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD LIPID LEVEL, COMPRISING, 17alpha-DIHYDROEQUILENIN
CA2159354A1 (en) *	1993-04-02	1994-10-13	R. Curtis Morris Jr.	Method and composition for treatment of osteoporosis
DE4326948C1 (de) *	1993-08-11	1994-11-17	Klaus Dr Med Umbreit	Verwendung von natürlichen Östrogenen zur Verlangsamung des Alterungsprozesses bei Männern
US5547948A (en) *	1995-01-17	1996-08-20	American Home Products Corporation	Controlled release of steroids from sugar coatings
AR014096A1 (es) *	1996-10-11	2001-02-07	Wyeth Corp	17 alfa,8,9-deshidroestradiol y 17 beta delta 8,9 deshidroestradiol, el uso de los mismos para la manufactura de un medicamento, una composicionfarmaceutica que los comprende y un procedimiento para su preparacion.
BR9809748A (pt) *	1997-04-07	2000-06-20	American Home Prod	Estra-5(10), 7-dienos com atividade estrogênica
ATE230413T1 (de) *	1997-05-02	2003-01-15	Wyeth Corp	Pharmazeutisch verträgliche salze von 3-hydroxy- estr-5(10)-en-17-on-3-sulfat die als östrogene aktiv sind
JP2001526654A (ja) *	1997-05-05	2001-12-18	アメリカン・ホーム・プロダクツ・コーポレイション	Ｂ環エストラトリエンジオールの硫酸エステル
DE19739916C2 (de) *	1997-09-11	2001-09-13	Hesch Rolf Dieter	Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
CA2331318A1 (en) *	1998-05-15	1999-11-25	James Harrison Pickar	Compositions comprising 2-phenyl-indole compounds and estrogen formulations
US6524616B1 (en) *	1999-06-25	2003-02-25	Wake Forest University Health Services	Compositions and methods for treating or preventing neurodegeneration and cognitive decline and dysfunction associated with alzheimer's disease, aging, other dementia related disorders and estrogen deficiency related conditions
AR027878A1 (es) *	1999-11-05	2003-04-16	Wyeth Corp	Metodos para identificar y utilizar compuestos inhibidores de amiloides
US20020151530A1 (en) *	2000-12-22	2002-10-17	Leonard Thomas W.	Method of treating hormonal deficiencies in women undergoing estrogen replacement therapy
CN1555266A (zh) *	2001-03-16	2004-12-15		激素替代疗法

2002
- 2002-03-15 AU AU2002338277A patent/AU2002338277B2/en not_active Ceased
- 2002-03-15 AR ARP020100942A patent/AR035946A1/es unknown
- 2002-03-15 PL PL02364675A patent/PL364675A1/xx not_active Application Discontinuation
- 2002-03-15 EA EA200301023A patent/EA200301023A1/ru unknown
- 2002-03-15 IL IL15794302A patent/IL157943A0/xx unknown
- 2002-03-15 CA CA002441252A patent/CA2441252A1/en not_active Withdrawn
- 2002-03-15 JP JP2002576948A patent/JP2004524354A/ja active Pending
- 2002-03-15 KR KR10-2003-7012066A patent/KR20030090673A/ko not_active Withdrawn
- 2002-03-15 MX MXPA03008366A patent/MXPA03008366A/es unknown
- 2002-03-15 EP EP02757788A patent/EP1368037A2/en not_active Ceased
- 2002-03-15 HU HU0500346A patent/HUP0500346A2/hu unknown
- 2002-03-15 CN CNA028101162A patent/CN1633299A/zh active Pending
- 2002-03-15 CN CNA2006100774667A patent/CN1879629A/zh active Pending
- 2002-03-15 SG SG200506473-8A patent/SG154323A1/en unknown
- 2002-03-15 WO PCT/US2002/007971 patent/WO2002078682A2/en not_active Ceased
- 2002-03-15 BR BR0208165-2A patent/BR0208165A/pt not_active IP Right Cessation
- 2002-03-15 US US10/099,356 patent/US20020173499A1/en not_active Abandoned
2003
- 2003-09-15 NO NO20034098A patent/NO20034098L/no not_active Application Discontinuation
- 2003-10-15 ZA ZA200308029A patent/ZA200308029B/xx unknown
2006
- 2006-02-08 US US11/349,712 patent/US20060142258A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CN1633299A (zh)	2005-06-29
JP2004524354A (ja)	2004-08-12
NO20034098D0 (no)	2003-09-15
MXPA03008366A (es)	2004-11-12
SG154323A1 (en)	2009-08-28
CA2441252A1 (en)	2002-10-10
US20060142258A1 (en)	2006-06-29
KR20030090673A (ko)	2003-11-28
IL157943A0 (en)	2004-03-28
US20020173499A1 (en)	2002-11-21
WO2002078682A3 (en)	2003-10-09
EA200301023A1 (ru)	2004-02-26
EP1368037A2 (en)	2003-12-10
WO2002078682A2 (en)	2002-10-10
ZA200308029B (en)	2010-04-28
PL364675A1 (en)	2004-12-13
AR035946A1 (es)	2004-07-28
BR0208165A (pt)	2004-03-30
CN1879629A (zh)	2006-12-20
AU2002338277B2 (en)	2007-11-22
HUP0500346A2 (hu)	2005-07-28

Legal Events

Date	Code	Title	Description
2010-11-01	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
DE50204184D1 (de)	2005-10-13	Espressobrüheinrichtung
ATE524462T1 (de)	2011-09-15	C5-modifizierte indazolylpyrrolotriazine
DE50214313D1 (de)	2010-05-12	Koaxialmagentventil
DE50208022D1 (de)	2006-10-12	Wischblatt
DE50206021D1 (de)	2006-05-04	Schlauchklemme
DE50204386D1 (de)	2006-02-09	Kreuztransducer
DE50212173D1 (de)	2008-06-12	sgängern
DE50209238D1 (de)	2007-02-22	Kugelgelenk
DE50204551D1 (de)	2005-11-17	Kugelgelenk
ATE335486T1 (de)	2006-09-15	Hydrazono-malonitrile
DE50211604D1 (de)	2008-03-13	Chlag
DE50209410D1 (de)	2007-03-22	Kugelgelenk
DE50208372D1 (de)	2006-11-23	Schrankaufhängevorrichtung
DE50204794D1 (de)	2005-12-08	Kugelgelenk
DE50211290D1 (de)	2008-01-10	Handzange
DE50203412D1 (de)	2005-07-21	Schwenkkolbenverdränger
NO20034098D0 (no)	2003-09-15	Östrogenerstatningsterapi
DE50203984D1 (de)	2005-09-22	Kugelgelenk
DE50208029D1 (de)	2006-10-12	Kugelgelenk
ATE355059T1 (de)	2006-03-15	Isoxazolopyridinone
DE50201862D1 (de)	2005-01-27	Messwandler
DE50203093D1 (de)	2005-06-16	Losradlager
ATA18372001A (de)	2005-07-15	Gelenksbolzenbaueinheit
ATE319694T1 (de)	2006-03-15	Phenylalkyne
DE50209293D1 (de)	2007-03-08	Amidpolymermasse